90
Participants
Start Date
August 7, 2024
Primary Completion Date
December 28, 2026
Study Completion Date
October 27, 2028
Ramucirumab
8 mg/kg IV Infusion
Paclitaxel
80 mg/M\^2 IV infusion
Sacituzumab Tirumotecan
3 mg/kg or 4 mg/kg IV Infusion
Rescue Medications
Participants receive rescue medications according to each approved drug's product label. Recommended rescue medications include antihistamines (histamine-1 and histamine-2 receptor antagonists), acetaminophen or equivalent, dexamethasone or equivalent infusion, and steroid mouth wash (dexamethasone or equivalent).
RECRUITING
Taipei Veterans General Hospital ( Site 8005), Taipei
RECRUITING
National Cheng Kung University Hospital ( Site 8001), Tainan City
RECRUITING
Hôpitaux Universitaires de Genève (HUG) ( Site 8701), Geneva
RECRUITING
Kantonsspital Graubünden-Medizin ( Site 8700), Chur
COMPLETED
Columbia University Irving Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical ( Site 8907), New York
RECRUITING
National Taiwan University Hospital-Oncology ( Site 8000), Taipei
RECRUITING
Hematology-Oncology Associates of Central NY, P.C. ( Site 8925), East Syracuse
RECRUITING
UPMC Hillman Cancer Center-UPMC ( Site 8904), Pittsburgh
RECRUITING
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 7200), Milan
RECRUITING
Facharztzentrum Eppendorf-Facharztzentrum Eppendorf ( Site 8807), Hamburg
RECRUITING
Centre Hospitalier Régional Universitaire de Brest - Hôpital-Institut de cancérologie et hématologi ( Site 7104), Brest
RECRUITING
Norton Cancer Institute - Downtown ( Site 8900), Louisville
RECRUITING
Universitaetsklinikum Duesseldorf-Gastroenterology, Hepatology and Infectiology ( Site 8802), Düsseldorf
RECRUITING
"IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori-Oncologia Medica ( Site 7207)", Meldola
RECRUITING
The Cancer and Hematology Centers ( Site 8912), Grand Rapids
RECRUITING
CIC. ( Site 7100), Lille
RECRUITING
Pitie Salpetriere University Hospital-Hepato-Gastro-Enterology ( Site 7102), Paris
RECRUITING
University of Texas MD Anderson Cancer Center ( Site 8920), Houston
RECRUITING
University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 8927), Tucson
RECRUITING
UCLA Hematology/Oncology - Santa Monica ( Site 8905), Los Angeles
RECRUITING
Beijing Cancer hospital-Digestive Oncology ( Site 7500), Beijing
RECRUITING
Fudan University Shanghai Cancer Center ( Site 7513), Shanghai
RECRUITING
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 7510), Hangzhou
RECRUITING
The First Affiliated Hospital of Nanchang University ( Site 7514), Nanchang
RECRUITING
The 900th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army ( Site 7501), Fuzhou
RECRUITING
The First Affiliated hospital of Xiamen University ( Site 7503), Xiamen
RECRUITING
China Medical University Hospital ( Site 8007), Taichung
RECRUITING
Henan Cancer Hospital ( Site 7504), Zhengzhou
RECRUITING
Xinjiang Medical University Cancer Hospital - Urumqi ( Site 7506), Ürümqi
RECRUITING
Bradford Hill Norte ( Site 8407), Antofagasta
RECRUITING
Centro de Investigación del Maule ( Site 8408), Talca
RECRUITING
Clínica Puerto Montt ( Site 8409), Port Montt
RECRUITING
FALP-UIDO ( Site 8400), Santiago
RECRUITING
Centro de Oncología de Precisión-Oncology ( Site 8404), Santiago
RECRUITING
Clínica UC San Carlos de Apoquindo ( Site 8405), Santiago
RECRUITING
Bradfordhill-Clinical Area ( Site 8401), Santiago
RECRUITING
Liga Norte Riograndense Contra o Câncer ( Site 8303), Natal
RECRUITING
Hospital Nossa Senhora da Conceição ( Site 8301), Porto Alegre
RECRUITING
IBCC - Instituto Brasileiro de Controle do Câncer ( Site 8304), São Paulo
RECRUITING
Oslo universitetssykehus, Radiumhospitalet ( Site 8501), Oslo
RECRUITING
Asan Medical Center-Department of Oncology ( Site 7901), Seoul
RECRUITING
Samsung Medical Center-Division of Hematology/Oncology ( Site 7900), Seoul
Merck Sharp & Dohme LLC
INDUSTRY